Perspective
The Success of Medicare Advantage Makes it a Better Policy Choice than ‘Medicare for All’
November 19, 2019
Featured Experts: Geoffrey Joyce, PhD
Research
All Research Featured Research
Evidence Base
Older People Have Smaller But Closer Social Networks
November 7, 2019
Featured Experts: Wändi Bruine de Bruin, MSc, PhD
Perspective
It’s Hard to Lower Drug Prices, If You Don’t Know What They Are
October 21, 2019
Featured Experts: Neeraj Sood, PhD
Perspective
CBO Estimate on Pelosi Drug Bill Misses its Long-Term Impact on Health
October 16, 2019
Featured Experts: Dana Goldman, PhD
Perspective
Accounting for Hope: Using ‘Mean Survival Gain’ to Price New Cancer Drugs
October 14, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Evidence Base
Who Would Have Believed it? Markets Can Reduce the ‘True’ Price of Cancer Drugs
September 28, 2019
Featured Experts: Dana Goldman, PhD
Perspective
California Saw Reduction in Out-of-Network Care from Affected Specialties after 2017 Surprise Billing Law
September 26, 2019
Featured Experts: Erin L. Duffy, PhD, MPH, Bich Ly, Erin Trish, PhD
Perspective
The Trump DOJ has Taken an Unexpected and Unworkable Position on the ACA
September 18, 2019
Perspective
Considerations For Expanding International Reference Pricing Beyond Medicare Part B
September 9, 2019
Featured Experts: Steven M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Evidence Base
Why Your Employer-Sponsored Insurance May Ultimately Not Be Good For You
September 9, 2019
Featured Experts: Dana Goldman, PhD
Perspective
Is This the Healthcare Policy Both Republicans and Democrats Can Agree On?
August 6, 2019
Featured Experts: Dana Goldman, PhD
Perspective
The Use of Vendors in Medicare Part B Drug Payment
August 2, 2019
Featured Experts: Paul Ginsburg, PhD, Steven M. Lieberman, MPhil, MA
Perspective
Don’t Let the New Kidney Health Initiative Fade from View
August 1, 2019
Featured Experts: Eugene Lin, MD, MS
Perspective
Rep. Ruiz’s Arbitration Proposal for Surprise Billing (H.R. 3502) Would Lead to Much Higher Costs and Deficits
July 16, 2019
Featured Experts: Paul Ginsburg, PhD, Erin Trish, PhD, Erin L. Duffy, PhD, MPH
Perspective
‘Meaningful Use’ of Cost-Measurement Systems — Incentives for Health Care Providers
July 10, 2019
Featured Experts: Paul Ginsburg, PhD
Perspective
CMS’s International Pricing Model for Medicare Part B Drugs: Implementation Issues
July 9, 2019
Featured Experts: Steven M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Perspective
We Need More Primary Care Physicians: Here’s Why and How
July 8, 2019
Featured Experts: Paul Ginsburg, PhD
